Moody's Investors Service assigned an "A2" rating to Baltimore-based University of Maryland Medical System's proposed $159.6 million of series 2017B bonds and $122.6 million of series 2017C bonds.
The rating assignment is based on a number of factors, including UMMS' solid market share and strong position as the clinical training venue for Baltimore-based University of Maryland School of Medicine.
The outlook is stable, reflecting Moody's Investors Service's expectation that UMMS will continue to generate stable margins.